HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Resistance to growth hormone releasing hormone and gonadotropins in Albright's hereditary osteodystrophy.

Abstract
Heterozygous inactivating mutations in the Gs alpha gene cause Albright's hereditary osteo-dystrophy (AHO). Consistent with the observation that only maternally inherited mutations lead to resistance to hormone action (pseudohypoparathyroidism type Ia [PHP-Ia), recent studies have provided evidence for a predominant maternal origin of Gs alpha transcripts in endocrine organs, such as thyroid, gonad and pituitary. Accordingly, patients with PHP-Ia display variable degrees of resistance to parathyroid hormone (PTH), thyroid stimulating hormone (TSH), gonadotropins and growth hormone (GH) releasing hormone (GHRH). Although the incidence and the clinical and biochemical characteristics of PTH and TSH resistance have been widely investigated and described, the cause and significance of the reproductive dysfunction in AHO is still poorly understood. The clinical finding of alterations of GH secretion in these patients was described for the first time only 2 years ago. The present report briefly reviews the literature focusing on the actual knowledge about these last two subjects.
AuthorsGiovanna Mantovani, Anna Spada
JournalJournal of pediatric endocrinology & metabolism : JPEM (J Pediatr Endocrinol Metab) Vol. 19 Suppl 2 Pg. 663-70 (May 2006) ISSN: 0334-018X [Print] Germany
PMID16789632 (Publication Type: Journal Article, Review)
Chemical References
  • Gonadotropins
  • Thyrotropin
  • Growth Hormone
  • Growth Hormone-Releasing Hormone
Topics
  • Female
  • Fibrous Dysplasia, Polyostotic (complications, metabolism, physiopathology)
  • Gonadotropins (metabolism)
  • Growth Hormone (metabolism)
  • Growth Hormone-Releasing Hormone (metabolism)
  • Humans
  • Hypogonadism (complications, metabolism)
  • Inheritance Patterns
  • Male
  • Pseudohypoparathyroidism (classification, complications, metabolism, physiopathology)
  • Thyrotropin (metabolism)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: